LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

DaVita Inc

Închisă

SectorSănătate

137.91 0.22

Rezumat

Modificarea prețului

24h

Curent

Minim

136.6

Maxim

139.47

Indicatori cheie

By Trading Economics

Venit

-117M

232M

Vânzări

-71M

3.2B

P/E

Medie Sector

13.334

51.198

EPS

2

Marjă de profit

7.204

Angajați

76,000

EBITDA

-131M

598M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+15.25% upside

Dividende

By Dow Jones

Următoarele câștiguri

5 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-2.3B

10B

Deschiderea anterioară

137.69

Închiderea anterioară

137.91

Sentimentul știrilor

By Acuity

19%

81%

38 / 380 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

DaVita Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 feb. 2025, 19:50 UTC

Principalele dinamici ale pieței

DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

21 mar. 2025, 08:19 UTC

Market Talk

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

15 iul. 2024, 08:17 UTC

Market Talk

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

Comparație

Modificare preț

DaVita Inc Așteptări

Obiectiv de preț

By TipRanks

15.25% sus

Prognoză pe 12 luni

Medie 158.75 USD  15.25%

Maxim 169 USD

Minim 145 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruDaVita Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

4 ratings

0

Cumpărare

3

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

142.36 / 144.275Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

38 / 380 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.